Serum application for the treatment of ocular surface disorders.
about
Autologous serum eye drops for dry eyeAutologous serum eye drops for dry eye syndromeSelenium compound protects corneal epithelium against oxidative stressSelenoprotein P controls oxidative stress in corneaAutologous serum eye drops for dry eye.Use of umbilical cord serum in ophthalmology.Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.Keratolimbal allograft in corneal reconstruction.The use of autologous serum tears in persistent corneal epithelial defects.Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.Current concepts in ocular surface reconstruction.Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat modelSelenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals.Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.Paradigm shifts, peregrinations and pixies in ophthalmology.Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells.Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.Latest advances in the treatment of corneal diseasesAutologous serum therapy in recalcitrant laser-assisted in situ keratomileusis-induced neurotrophic epitheliopathy.Fulminant bilateral Haemophilus influenzae keratitis in a patient with hypovitaminosis A treated with contaminated autologous serum.The effect of therapeutic human serum drops on corneal stromal wound-healing activity.Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.Beneficial effect of daidzin in dry eye rat model through the suppression of inflammation and oxidative stress in the cornea.
P2860
Q24200233-FEE24F09-7EF2-43E2-915A-CA28F21EC881Q24234791-ED5C16A4-6729-4AF2-9238-3F2BCF50771BQ28484037-B95C189F-3D23-48EE-BD4A-A7B90EBD49FEQ28748239-ACA624A0-BFD3-46B1-8B45-8AB427DAB5FCQ30235522-26F9536B-B714-4A81-9952-57EA89FFA644Q30421187-14718BFB-E724-43B6-862A-98EE51421F21Q35592019-AA7C051B-2269-4D53-80B2-1B0732B4223CQ35740149-107BBD03-ABEC-4DC2-BC45-69C04E71B987Q35797113-E480E9B0-751C-454C-AF94-480881D54F44Q36169872-F60D93A6-012E-4057-A972-C8009EDC95ACQ36195255-36E01798-49E8-4A4C-ACE4-E5C86ADE2678Q36876867-BDDFE139-762E-404E-B1DC-81960E5AA3D1Q39197717-524C8C40-3F0A-41D8-A55A-42A38E58B9A3Q39210170-2DCDB07D-E167-4897-82C3-BA6CF6FF4A2BQ39439138-E00EB973-2CDA-4D46-86B9-6B51FA302881Q40306063-E39C0BF8-4694-44BD-942E-A10B0E56914EQ40997622-5E0CAE41-E6A4-451D-B588-60BAA84E0960Q42360092-E46F8B2B-4B24-4F51-B8FC-A235129453BAQ42360094-D3DA9C0C-4E19-4EDB-BC56-7C4D9E3DDC6DQ42588728-516B6E40-A0D6-4220-9616-AEE24660B092Q46434000-14E4A4CD-3D65-4C12-8AEF-5E2279895158Q52661549-DD94A499-EF56-4B95-825B-41038F960C07Q55268786-DB3E536C-6BC0-4137-9C7C-7A5A92F896C3
P2860
Serum application for the treatment of ocular surface disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Serum application for the treatment of ocular surface disorders.
@ast
Serum application for the treatment of ocular surface disorders.
@en
Serum application for the treatment of ocular surface disorders.
@nl
type
label
Serum application for the treatment of ocular surface disorders.
@ast
Serum application for the treatment of ocular surface disorders.
@en
Serum application for the treatment of ocular surface disorders.
@nl
prefLabel
Serum application for the treatment of ocular surface disorders.
@ast
Serum application for the treatment of ocular surface disorders.
@en
Serum application for the treatment of ocular surface disorders.
@nl
P1476
Serum application for the treatment of ocular surface disorders.
@en
P2093
P304
P356
10.1097/00004397-200010000-00009
P577
2000-01-01T00:00:00Z